Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials - ScienceDirect
PPT - ESMO/ECCO Presidential Session III PowerPoint Presentation, free download - ID:5764158
IJMS | Free Full-Text | Prognostic and Predictive Cross-Roads of Microsatellite Instability and Immune Response to Colon Cancer
3. Cancer du côlon non métastatique | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer | NEJM
Adjuvant chemotherapy for colorectal cancer - ScienceDirect
Frontiers | Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
Duration of Oxaliplatin-Containing Adjuvant Therapy for Stage III Colon Cancer: ASCO Clinical Practice Guideline | Journal of Clinical Oncology
Cancers | Free Full-Text | Adjuvant Chemotherapy for Stage III Colon Cancer
Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient
Median cycle of XELOX adjuvant chemotherapy received by patients for... | Download Scientific Diagram
Cancers | Free Full-Text | The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer
Trials With XELOX-Based Neoadjuvant Chemoradiotherapy With or Without... | Download Table
Figure 2 from The efficacy of XELOX and FOLFOX adjuvant chemotherapy in stage III colorectal cancer patients with low preoperative serum albumin levels | Semantic Scholar
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study - Annals of Oncology
Proposed decision algorithm for adjuvant therapy in colon cancer LN:... | Download Scientific Diagram
JCM | Free Full-Text | The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer
Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience | Cancer Communications | Full Text
Bevacizumab (Bev) in combination with XELOX or FOLFOX-4: updated efficacy results from XELOX-1 / NO16966, a randomized phase III trial in first-line metastatic. - ppt video online download
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer | NEJM
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials - The Lancet Oncology
Metachronous pulmonary and pancreatic metastases arising from sigmoid colon cancer: A case report
Frontiers | Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
Adjuvant chemotherapy for rectal cancer: Current evidence and recommendations for clinical practice - ScienceDirect
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer | British Journal of Cancer
Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience | Cancer Communications | Full Text
